Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel…
Pharmaceuticals, Biotechnology and Life Sciences
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel…
Senthil Sundaram Stepping Down as Chief Executive Officer for Health ReasonsFOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — Terns…
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions,…
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the…
Updated clinical & translational data on BALLI-01 trial (evaluating UCART22 in r/r B-cell ALL) presented at the EHA annual meeting Clinical…
BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…
– Continued progress in clinical development across portfolio –– Public equity offering and concurrent private placement with gross proceeds of…
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing immunotherapeutics designed to…
– Phase 2 data readouts from ongoing chronic hepatitis B and chronic hepatitis delta programs on track for Q4 2023…
REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel…